Showing 6,081 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

HIV treatment

Eviplera Factsheet

About HIV
April 2021
HIV treatment

Genvoya Factsheet

About HIV
April 2021
Viral load

Near point-of-care viral load testing enables quick clinical action for people with high viral load

News
2 April 2021
People with limited treatment options

Heavily treatment-experienced people in Europe do not have a higher risk of clinical events

News
1 April 2021
Pregnancy and vertical transmission

Antiretrovirals for HIV Don’t Raise Birth Defect Risk

Editor's pick
POZ
27 March 2021
Drug interactions & pharmacokinetics

Elderly women more likely than men to have inappropriately prescribed medicines

News
25 March 2021
Injectable & long-acting HIV treatment

Top 5 stories on injectable HIV treatment and prevention from CROI 2021

News
23 March 2021
Health problems & ageing

Top 5 stories on HIV, ageing and co-morbidities from CROI 2021

News
23 March 2021
Treatment guidelines

Top 5 stories on HIV treatment and care in Africa from CROI 2021

News
23 March 2021
Treatment guidelines

WHO publishes new clinical recommendations on HIV prevention, infant diagnosis, antiretroviral therapy initiation and monitoring

Editor's pick
World Health Organization
18 March 2021
Adherence

FTC-TP in Dried Blood Spots Predicts Future Detectable Viral Load in US Study

Editor's pick
NATAP
17 March 2021
Cancer

Delayed Start of HIV Therapy Tied to Small Increase in Risk of AIDS-Related Cancers

Editor's pick
Medscape (requires free registration)
17 March 2021
Weight gain & lipodystrophy

HIV research: Increased weight gain with TAF medication

Editor's pick
EurekAlert
17 March 2021
Weight gain & lipodystrophy

What are the roles of TAF and integrase inhibitors in weight gain?

News
16 March 2021
Drug interactions & pharmacokinetics

PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women

News
16 March 2021
Treatment simplification strategies

Four-days-on, three-days-off treatment regimen still looks effective after two years

News
16 March 2021
Pregnancy and vertical transmission

Another HIV Tivicay Birth Outcome: Better Infant Survival

Editor's pick
Medscape (requires free registration)
15 March 2021
Injectable & long-acting HIV treatment

Injectable HIV medications must be practical and affordable, conference hears

News
15 March 2021
Transgender people

Gender-affirming surgery associated with sustained viral suppression

News
15 March 2021
Contraception

Doubling the dose of emergency contraception is a safe and effective way of overcoming efavirenz interaction

News
15 March 2021
PrEP science

Interactions between PrEP and gender-affirming hormone therapy A research briefing

About HIV
March 2021
Injectable & long-acting HIV treatment

Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV

Editor's pick
Gilead press release
15 March 2021
Injectable & long-acting HIV treatment

Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years

News
12 March 2021
TB treatment

Should TB Treatment Move into Long-Acting Injectables?

Editor's pick
Contagion Live
11 March 2021